Effect of timing of restarting antiplatelet therapy on chronic subdural hematoma after drilling and drainage in patients on long-term oral antiplatelet agents
CHEN Zhifeng
YANG Xiaobo
LI Delong
WANG Lintao
Abstract：Chronic subdural hematoma(CSDH)is a common neurosurgical disease that can lead to symptoms such as headache,impaired consciousness,and neurological deficits,and may be life-threatening in severe cases.Symptomatic CSDH is typically treated with burr hole drainage.Postoperative hemorrhage and hematoma recurrence remain major complications.Antiplatelet drugs play a crucial role in the prevention and treatment of cardiovascular and cerebrovascular diseases,effectively reducing the incidence of myocardial infarction and ischemic stroke.Therefore,for CSDH patients on long-term antiplatelet medication,the optimal timing for restarting antiplatelet therapy after burr hole drainage remains controversial.Restarting an-tiplatelet therapy too early may increase the risk of postoperative bleeding and hematoma recurrence,while delaying its restart may elevate the risk of thrombosis,leading to thromboembolic events.Thus,a reasonable assessment of the timing for restarting antiplatelet therapy is crucial for improving the prognosis of CSDH patients.This article reviews the research progress on restart-ing antiplatelet therapy after burr hole drainage for CSDH.
Keywords：chronic subdural hematomaburr hole drainageantiplatelet drugsrestarting timing
Publication Date：2026-01-25
Online Publishing Date：2026-03-16(First online date of this platform, not the publication date of the document)
Pages：5( 55-59 )